The loss of Cav1 and FLOT1 in ATV-treated cells, at growth inhibitory concentrations, strongly indicate that cholesterol and Cav1 are important for NSCLC cell growth. The gene discussed is CAV1; the disease is non-small cell lung carcinoma.